Foydalanuvchi:Xatchiman/Poliomiyelitga qarshi vaksina
Polioga qarshi vaksina — poliomiyelit (polio) ning oldini olish uchun qo'llaniladigan vaksinadir[1][2]. Uning ikki xili: inyeksiya orqali beriladigan faolsizlashtirilgan poliovirus (IPV) va og‘iz orqali beriluvchi zaiflashtirilgan poliovirus (OPV) dan foydalaniladi[3]. Jahon sog‘liqni saqlash tashkiloti barcha bolalarga poliomiyelitga qarshi to‘liq emlanishni tavsiya qiladi[4]. Ushbu ikki turdagi vaksina dunyoning aksariyat qismidan poliomiyelitni yo‘q qildi[5][6] va har yili qayd etilgan holatlar sonini 1988-yil holatidagi 350 000 dan 2018-yilda 33 taga kamaytirdi[7][8].
Faolsizlashtirilgan poliomiyelitga qarshi vaksinalar mutlaqo xavfsizdir[9]. Ukol qilingan joyda yengil qizarish yoki og‘riq paydo bo‘lishi mumkin[10]. Vaksina og‘iz orqali yuborilganda million dozadan taxminan uchta emlash bilan bog‘liq paralitik poliomiyelitga olib keluvchi holat kuzatilishi mumkin[11]. Bu esa poliomiyelit infeksiyasidan falaj bo‘lgan har million kishidan 5000 holat bilan taqqoslanadi[12]. Ikkala turdagi vaksinani ham homiladorlik paytida va OIV/OITS bilan kasallanganlarda qo'llash xavfsiz[13].
Poliomiyelitga qarshi vaksinaning birinchi muvaffaqiyatli namoyishi 1950-yilda Hilary Koprowski tomonidan odamlarga ichirilgan tirik, ammo zaiflashtirilgan virus bo‘lgan[14]. Vaksinadan Qo‘shma Shtatlarda foydalanishga ruxsat berilmagan, ammo boshqa joylarda undan muvaffaqiyatli foydalanilgan[15]. Jonas Salk tomonidan ishlab chiqilgan faolsizlantirilgan (o‘ldirilgan) poliomiyelitga qarshi vaksinaning muvaffaqiyatli natijasi1955-yilda e’lon qilingan[16][17]. Boshqa zaiflashtirilgan tirik og‘iz orqali yuboriladigan poliomiyelitga qarshi vaksina Albert Sabin tomonidan ishlab chiqilgan va 1961-yilda tijorat maqsadida foydalanishga kiritilgan[18][19].
Polioga qarshi vaksina Jahon sog‘liqni saqlash tashkilotining asosiy dori vositalari ro‘yxatiga kiritilgan[20].
Tibbiy maqsadlarda qo'llash
[tahrir | manbasini tahrirlash]Emlash orqali virusning odamdan odamga yuqishini to‘xtatish poliomiyelitni global yo‘q qilishda muhim ahamiyatga ega[21], chunki normal immunitet funksiyasiga ega bo‘lgan odamlarda poliovirus uchun uzoq muddatli tashuvchi holat mavjud emas. Poliomiyelit viruslari tabiatda primat bo‘lmagan rezervuarga ega emas va virusning uzoq vaqt davomida atrof-muhitda omon qolishi uzoq muddat davom etadi. [[Turkum:Vaksinalar]]
- ↑ "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record 91 (12): 145–68. 2016. PMID 27039410.
- ↑ "Polio vaccines: WHO position paper – June 2022". Weekly Epidemiological Record 97 (25): 277–300. 2022.
- ↑ "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record 91 (12): 145–68. 2016. PMID 27039410.
- ↑ "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record 91 (12): 145–68. 2016. PMID 27039410.
- ↑ "Eradicating polio: today's challenges and tomorrow's legacy". Annals of Tropical Medicine and Parasitology 100 (5–6): 401–413. 2006. doi:10.1179/136485906X97354. PMID 16899145.
- ↑ "Control of paralytic poliomyelitis in the United States". Reviews of Infectious Diseases 6 (Suppl 2): S424–S426. 1984. doi:10.1093/clinids/6.Supplement_2.S424. PMID 6740085.
- ↑ „Global Wild Poliovirus 2014–2019“. 2019-yil 3-fevralda asl nusxadan arxivlangan. Qaraldi: 2019-yil 3-fevral.
- ↑ „Does polio still exist? Is it curable?“. World Health Organization (WHO). 2018-yil 29-mayda asl nusxadan arxivlangan. Qaraldi: 2018-yil 21-may.
- ↑ "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record 91 (12): 145–68. 2016. PMID 27039410.
- ↑ "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record 91 (12): 145–68. 2016. PMID 27039410.
- ↑ "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record 91 (12): 145–68. 2016. PMID 27039410.
- ↑ „Poliomyelitis“. World Health Organization (WHO). 2017-yil 18-aprelda asl nusxadan arxivlangan. Qaraldi: 2017-yil 25-aprel.
- ↑ "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record 91 (12): 145–68. 2016. PMID 27039410.
- ↑ „Hilary Koprowski, Who Developed First Live-Virus Polio Vaccine, Dies at 96“. The New York Times (2013-yil 20-aprel). 2017-yil 25-avgustda asl nusxadan arxivlangan. Qaraldi: 2017-yil 8-sentyabr.
- ↑ „Hilary Koprowski, Who Developed First Live-Virus Polio Vaccine, Dies at 96“. The New York Times (2013-yil 20-aprel). 2017-yil 25-avgustda asl nusxadan arxivlangan. Qaraldi: 2017-yil 8-sentyabr.
- ↑ "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record 91 (12): 145–68. 2016. PMID 27039410.
- ↑ Vaccination: A History. John Libbey Eurotext, 2011 — 395-bet. ISBN 978-2742007752.
- ↑ "Polio vaccines: WHO position paper – March, 2016". Weekly Epidemiological Record 91 (12): 145–68. 2016. PMID 27039410.
- ↑ "Pioneering figures in medicine: Albert Bruce Sabin – inventor of the oral polio vaccine". The Kurume Medical Journal 52 (3): 111–116. 2005. doi:10.2739/kurumemedj.52.111. PMID 16422178.
- ↑ The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization, 2023. WHO/MHP/HPS/EML/2023.02.
- ↑ "Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative". American Journal of Epidemiology 150 (10): 1001–1021. November 1999. doi:10.1093/oxfordjournals.aje.a009924. PMID 10568615.